Orna Therapeutics, a biotechnology company dedicated to engineering immune cells in vivo to treat oncology and autoimmune diseases, announced the appointment of Joseph Bolen, Ph.D., as...
Alector, a late-stage clinical biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, announced that Gary Romano, M.D., Ph.D., has...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
Genomize, a leader in high-end digital solutions for bioinformatics analysis of next-generation sequencing (NGS) data, and Genomenon, a leading genomic intelligence company, announced their...
Avanos Medical, Inc., a leading medical technology company, announced the appointment of David Pacitti as its new chief executive officer, effective April 14, 2025.
Pacitti joins Avanos...
